VALN (VALN) Stock Price & Analysis
VALN (VALN) rose 0.00% to USD 4.78 as of July 26, 2026 at 09:45 UTC, according to Nexqual real-time market data.
VALN last closed at USD 4.78; the session ranged USD 4.76–4.83 on volume of 5,914 shares. Market capitalization is $488.13M, with a 52-week range of USD 4.75–12.25 (NMS). Source: Nexqual, July 26, 2026 at 09:45 UTC.
Key Statistics (as of July 26, 2026 at 09:45 UTC)
| Price | USD 4.78 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.78 |
| Open | USD 4.8 |
| Day Range | USD 4.76 – 4.83 |
| 52-Week Range | USD 4.75 – 12.25 |
| Volume | 5,914 shares |
| Market Cap | $488.13M |
| Exchange | NMS |
Technical Analysis (VALN)
Nexqual's technical model rates VALN "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 09:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.27 (neutral) |
| vs SMA50 | Below (USD 5.42) |
| MACD | -0.16 (negative) |
Analyst Ratings (VALN)
Wall Street analysts rate VALN "None" based on 4 analysts, with a mean price target of USD 12.2 (range USD 4.8–18), per Nexqual as of July 26, 2026 at 09:45 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 12.2 |
| High Target | USD 18 |
| Low Target | USD 4.8 |
| Buy / Hold / Sell | 3 / 0 / 1 |
Earnings (VALN)
| Next Earnings Date | 2026-08-13 |
|---|---|
| EPS Estimate | USD -0.08 |
| Revenue Estimate | $37.72M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.42 vs est -0.21 ▼ miss |
| 2025-09-30 | USD -0.6 vs est -0.26 ▼ miss |
| 2025-06-30 | USD -0.16 vs est -0.19 ▲ beat |
Source: Nexqual, July 26, 2026 at 09:45 UTC.
Financials & Fundamentals (VALN)
| Total Revenue | $156.33M |
|---|---|
| Revenue Growth (YoY) | -37.20% |
| Gross Margin | -25.27% |
| Operating Margin | -76.67% |
| Profit Margin | -88.30% |
| ROE | -109.57% |
| Debt / Equity | 273.15 |
| Current Ratio | 2.14 |
| Total Cash | $105.27M |
| Total Debt | $209.50M |
| Free Cash Flow | $-31.01M |
Source: Nexqual, July 26, 2026 at 09:45 UTC.
Financial Health Score (VALN)
Nexqual rates VALN's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 09:45 UTC.
| Growth | Mixed — Revenue +3.0% YoY (annual), slow |
|---|---|
| Profitability | Critical — Gross margin -25%, operating -77% |
| Balance Sheet | Weak — $105M cash vs $210M debt |
| Cash Flow | Weak — FCF negative: -$31M, burning cash |
| Efficiency | Critical — ROE -110%, ROA -14.5% |
Ownership (VALN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.62% |
| Shares Outstanding | 102.12M |
| Float | 73.88M |
| Short % of Float | +0.16% |
Source: Nexqual, July 26, 2026 at 09:45 UTC.
Leadership (VALN)
VALN is led by Thomas Lingelbach (age 62), President, CEO & Director, per Nexqual as of July 26, 2026 at 09:45 UTC.
| President, CEO & Director | Thomas Lingelbach (age 62) |
|---|---|
| Chief Financial Officer | Peter Buhler (age 54) |
| Chief Operating Officer | Vincent Dequenne (age 58) |
| Chief Scientific Officer | Hanneke Schuitemaker (age 60) |
| Vice President of Investor Relations | Joshua Drumm |
Major Backers & Investors (VALN)
Notable institutional backers of VALN include Frazier Life Sciences Management, L.P. , Novo Holdings A/S, General American Investors Company Inc, according to Nexqual as of July 26, 2026 at 09:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Frazier Life Sciences Management, L.P. | 2.42% |
| Novo Holdings A/S | 1.11% |
| General American Investors Company Inc | 0.74% |
Source: Nexqual, July 26, 2026 at 09:45 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MOLN | Molecular Partners AG | USD 3.89 | ▼ 2.02% |
| PHVS | Pharvaris N.V. | USD 34.17 | ▼ 0.55% |
| IPHA | Innate Pharma S.A. | USD 1.78 | ▲ 0.28% |
| TYRA | Tyra Biosciences, Inc. | USD 30.63 | ▲ 0.13% |
| LYEL | Lyell Immunopharma, Inc. | USD 12.63 | ▼ 1.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 09:45 UTC. This page is informational and not investment advice.